OTCMKTS:ACRGF

Acreage Competitors

$2.77
-0.03 (-0.89 %)
(As of 09/22/2020)
Add
Compare
Today's Range
$2.75
Now: $2.77
$2.84
50-Day Range
$2.77
MA: $2.77
$2.77
52-Week Range
$1.47
Now: $2.77
$9.11
Volume131,600 shs
Average Volume340,301 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

Acreage (OTCMKTS:ACRGF) Vs. ABAHF, APPB, AYRSF, CANB, CNTMF, and CWBHF

Should you be buying ACRGF stock or one of its competitors? Companies in the industry of "drug manufacturers - specialty & generic" are considered alternatives and competitors to Acreage, including Abacus Health Products (ABAHF), Applied Biosciences (APPB), Ayr Strategies (AYRSF), Can B (CANB), Cansortium (CNTMF), and Charlotte's Web (CWBHF).

Acreage (OTCMKTS:ACRGF) and Abacus Health Products (OTCMKTS:ABAHF) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, profitability, analyst recommendations, earnings, risk, valuation and dividends.

Valuation & Earnings

This table compares Acreage and Abacus Health Products' revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AcreageN/AN/AN/AN/AN/A
Abacus Health ProductsN/AN/AN/AN/AN/A

Analyst Ratings

This is a summary of current recommendations and price targets for Acreage and Abacus Health Products, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Acreage01202.67
Abacus Health Products0000N/A

Acreage presently has a consensus target price of $8.4333, suggesting a potential upside of 204.45%. Given Acreage's higher probable upside, analysts plainly believe Acreage is more favorable than Abacus Health Products.

Profitability

This table compares Acreage and Abacus Health Products' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
AcreageN/AN/AN/A
Abacus Health ProductsN/AN/AN/A

Summary

Acreage beats Abacus Health Products on 2 of the 2 factors compared between the two stocks.

Acreage (OTCMKTS:ACRGF) and Applied Biosciences (OTCMKTS:APPB) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, profitability, analyst recommendations, earnings, risk, valuation and dividends.

Valuation & Earnings

This table compares Acreage and Applied Biosciences' revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AcreageN/AN/AN/AN/AN/A
Applied BiosciencesN/AN/AN/AN/AN/A

Analyst Ratings

This is a summary of current recommendations and price targets for Acreage and Applied Biosciences, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Acreage01202.67
Applied Biosciences0000N/A

Acreage presently has a consensus target price of $8.4333, suggesting a potential upside of 204.45%. Given Acreage's higher probable upside, analysts plainly believe Acreage is more favorable than Applied Biosciences.

Profitability

This table compares Acreage and Applied Biosciences' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
AcreageN/AN/AN/A
Applied BiosciencesN/AN/AN/A

Summary

Acreage beats Applied Biosciences on 2 of the 2 factors compared between the two stocks.

Acreage (OTCMKTS:ACRGF) and Ayr Strategies (OTCMKTS:AYRSF) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, profitability, analyst recommendations, earnings, risk, valuation and dividends.

Valuation & Earnings

This table compares Acreage and Ayr Strategies' revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AcreageN/AN/AN/AN/AN/A
Ayr StrategiesN/AN/AN/AN/AN/A

Analyst Ratings

This is a summary of current recommendations and price targets for Acreage and Ayr Strategies, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Acreage01202.67
Ayr Strategies01602.86

Acreage presently has a consensus target price of $8.4333, suggesting a potential upside of 204.45%. Ayr Strategies has a consensus target price of $34.8571, suggesting a potential upside of 63.96%. Given Acreage's higher probable upside, analysts plainly believe Acreage is more favorable than Ayr Strategies.

Profitability

This table compares Acreage and Ayr Strategies' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
AcreageN/AN/AN/A
Ayr StrategiesN/AN/AN/A

Summary

Ayr Strategies beats Acreage on 2 of the 3 factors compared between the two stocks.

Acreage (OTCMKTS:ACRGF) and Can B (NASDAQ:CANB) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, profitability, analyst recommendations, earnings, risk, valuation and dividends.

Valuation & Earnings

This table compares Acreage and Can B's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AcreageN/AN/AN/AN/AN/A
Can BN/AN/AN/AN/AN/A

Profitability

This table compares Acreage and Can B's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
AcreageN/AN/AN/A
Can BN/AN/AN/A

Analyst Ratings

This is a summary of current recommendations and price targets for Acreage and Can B, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Acreage01202.67
Can B0000N/A

Acreage presently has a consensus target price of $8.4333, suggesting a potential upside of 204.45%. Given Acreage's higher probable upside, analysts plainly believe Acreage is more favorable than Can B.

Summary

Acreage beats Can B on 2 of the 2 factors compared between the two stocks.

Cansortium (OTCMKTS:CNTMF) and Acreage (OTCMKTS:ACRGF) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, dividends, risk, profitability, earnings and institutional ownership.

Earnings & Valuation

This table compares Cansortium and Acreage's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CansortiumN/AN/AN/AN/AN/A
AcreageN/AN/AN/AN/AN/A

Profitability

This table compares Cansortium and Acreage's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
CansortiumN/AN/AN/A
AcreageN/AN/AN/A

Analyst Recommendations

This is a breakdown of recent ratings and target prices for Cansortium and Acreage, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Cansortium00103.00
Acreage01202.67

Cansortium presently has a consensus target price of $1.20, suggesting a potential upside of 41.18%. Acreage has a consensus target price of $8.4333, suggesting a potential upside of 204.45%. Given Acreage's higher probable upside, analysts clearly believe Acreage is more favorable than Cansortium.

Summary

Acreage beats Cansortium on 2 of the 3 factors compared between the two stocks.

Charlotte's Web (OTCMKTS:CWBHF) and Acreage (OTCMKTS:ACRGF) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, dividends, risk, profitability, earnings and institutional ownership.

Earnings & Valuation

This table compares Charlotte's Web and Acreage's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Charlotte's WebN/AN/AN/AN/AN/A
AcreageN/AN/AN/AN/AN/A

Profitability

This table compares Charlotte's Web and Acreage's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Charlotte's WebN/AN/AN/A
AcreageN/AN/AN/A

Analyst Recommendations

This is a breakdown of recent ratings and target prices for Charlotte's Web and Acreage, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Charlotte's Web01302.75
Acreage01202.67

Charlotte's Web presently has a consensus target price of $7.25, suggesting a potential upside of 60.86%. Acreage has a consensus target price of $8.4333, suggesting a potential upside of 204.45%. Given Acreage's higher probable upside, analysts clearly believe Acreage is more favorable than Charlotte's Web.

Summary

Charlotte's Web beats Acreage on 2 of the 3 factors compared between the two stocks.


Acreage Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
ABAHF
Abacus Health Products
0.4$4.84-5.4%$0.00N/A0.00Gap Up
APPB
Applied Biosciences
0.5$0.25-92.0%$0.00N/A0.00High Trading Volume
Gap Down
AYRSF
Ayr Strategies
1.4$21.26-1.0%$0.00N/A0.00High Trading Volume
Gap Down
Can B logo
CANB
Can B
0.4$0.55-1.8%$0.00N/A0.00High Trading Volume
Cansortium logo
CNTMF
Cansortium
1.1$0.85-1.8%$0.00N/A0.00
Charlotte's Web logo
CWBHF
Charlotte's Web
1.3$4.51-0.8%$0.00N/A0.00
Choom logo
CHOOF
Choom
0.5$0.10-7.1%$0.00N/A0.00
CPHRF
Cipher Pharmaceuticals
1.2$1.08-0.5%$0.00N/A0.00Gap Up
CLS Holdings USA logo
CLSH
CLS Holdings USA
0.7$0.22-8.6%$0.00N/A0.00
Cosmos logo
COSM
Cosmos
0.5$5.80-0.9%$0.00N/A0.00
Cresco Labs logo
CRLBF
Cresco Labs
1.5$12.73-1.1%$0.00N/A0.00
Curaleaf logo
CURLF
Curaleaf
1.6$14.70-0.1%$0.00N/A0.00
HMDEF
DionyMed Brands
0.5$2.25-1.5%$0.00N/A0.00High Trading Volume
Easton Pharmaceuticals logo
EAPH
Easton Pharmaceuticals
0.5$0.00-29.4%$0.00N/A0.00Gap Up
Elixinol Global logo
ELLXF
Elixinol Global
0.8$0.15-3.4%$0.00N/A0.00Gap Up
EVIO
EVIO
0.6$0.00-3.7%$0.00N/A0.00Gap Down
Flower One logo
FLOOF
Flower One
0.4$0.28-3.2%$0.00N/A0.00
Golden Leaf logo
GLDFF
Golden Leaf
0.5$0.05-5.0%$0.00N/A0.00
Green Growth Brands logo
GGBXF
Green Growth Brands
0.4$0.01-3.6%$0.00N/A0.00Gap Up
Green Thumb Industries logo
GTBIF
Green Thumb Industries
1.7$28.10-3.9%$0.00N/A0.00
GTEC logo
GGTTF
GTEC
0.6$0.62-3.4%$0.00N/A0.00
Harvest Health & Recreation logo
HRVSF
Harvest Health & Recreation
1.3$3.06-2.0%$0.00N/A0.00
Hemp Naturals logo
HPMM
Hemp Naturals
0.6$0.01-3.3%$0.00N/A0.00
Hexo logo
HYYDF
Hexo
0.6$5.30-1.8%$0.00N/A0.00
Hikma Pharmaceuticals logo
HKMPY
Hikma Pharmaceuticals
0.4$59.68-4.6%$0.00N/A0.00Gap Up
iAnthus Capital logo
ITHUF
iAnthus Capital
0.6$0.24-7.5%$0.00N/A0.00Gap Up
Icanic Brands logo
ICNAF
Icanic Brands
0.6$0.36-0.6%$0.00N/A0.00
KNHBF
ICC International Cannabis
0.6$0.43-0.0%$0.00N/A0.00
Invictus MD Strategies logo
IVITF
Invictus MD Strategies
0.6$0.04-4.6%$0.00N/A0.00Gap Up
Isodiol International logo
ISOLF
Isodiol International
0.4$0.06-13.1%$0.00N/A0.00Gap Up
Khiron Life Sciences logo
KHRNF
Khiron Life Sciences
1.4$0.45-0.9%$0.00N/A0.00
KHTRF
Knight Therapeutics
1.2$4.22-0.3%$0.00N/A0.00High Trading Volume
Marijuana Company of America logo
MCOA
Marijuana Company of America
0.5$0.01-3.6%$0.00N/A0.00
Medical Marijuana logo
MJNA
Medical Marijuana
0.6$0.06-3.1%$0.00N/A0.00Gap Down
MediPharm Labs logo
MEDIF
MediPharm Labs
1.2$0.42-8.2%$0.00N/A0.00
MedMen Enterprises logo
MMNFF
MedMen Enterprises
0.8$0.37-3.6%$0.00N/A0.00
MERCK Kommanditgesellschaft auf Aktien logo
MKKGY
MERCK Kommanditgesellschaft auf Aktien
0.5$35.31-1.4%$0.00N/A0.00High Trading Volume
MJardin Group logo
MJARF
MJardin Group
1.1$0.07-2.6%$0.00N/A0.00Gap Up
MYHI
Mountain High Acquisitions
0.5$0.02-0.0%$0.00N/A0.00Gap Down
PHCEF
Pharmacielo
0.7$2.42-0.8%$0.00N/A0.00
Plus Products logo
PLPRF
Plus Products
1.1$0.57-0.9%$0.00N/A0.00Gap Down
Premier Biomedical logo
BIEI
Premier Biomedical
0.5$0.00-4.0%$0.00N/A0.00
PCYN
Procyon
0.4$0.70-7.1%$0.00N/A0.00Gap Up
Pure Global Cannabis logo
PRCNF
Pure Global Cannabis
0.7$0.01-5.5%$0.00N/A0.00
SANP
Santo Mining
0.5$0.01-7.2%$0.00N/A0.00Gap Down
Shionogi & Co., Ltd. logo
SGIOY
Shionogi & Co., Ltd.
0.5$13.39-1.6%$0.00N/A0.00
DNPUF
Sumitomo Dainippon Pharma
0.5$17.40-7.8%$0.00N/A0.00Gap Up
TerrAscend logo
TRSSF
TerrAscend
1.7$10.11-2.4%$0.00N/A0.00Gap Down
The Flowr logo
FLWPF
The Flowr
1.5$0.26-2.0%$0.00N/A0.00
The Supreme Cannabis logo
SPRWF
The Supreme Cannabis
1.0$0.32-0.8%$0.00N/A0.00Analyst Downgrade
Gap Up
This page was last updated on 4/12/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.